Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center (FICAN West) have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin. In the future, PRECSIT could...
The University of Arizona Cancer Center has received a $6.9 million grant for skin cancer prevention research thanks to the National Institutes of Health’s National Cancer Institute. This Arizona-based team of researchers seek to develop new strategies and techniques...
A new treatment based on combining two drugs—nivolumab and ipilimumab—may represent a milestone in how we treat skin cancer patients. More than half of these patients can now survive the condition (considered untreatable just a decade ago) thanks to a study led by the...
The Netherlands’ Erasmus University Medical Center and an international team of investigators has determined that SkinVision, the first CE-marked skin cancer application thoroughly tested in clinical studies, reports a sensitivity of 95.1% in detecting the most common...
Researchers from the Perelman School of Medicine at the University of Pennsylvania have identified a key regulator that impedes skin replacement—a blockage which can trigger the development of skin cancer. Published in Cell Reports, the team report that the skin’s...
Researchers from Denmark’s Aarhus University Hospital have shown that antibiotics administered to treat Staphylococcus aureus appeared to inhibit disease among patients with advanced cutaneous T-cell lymphoma. The prospective study results were published in Blood and...
